Company Filing History:
5 out of 131 
1 out of 924 
1 out of 20 Years Active: 1997-2001
Title: The Innovative Contributions of Matthew Wecker
Introduction
Matthew Wecker is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of biotechnology, particularly in the development of methods for identifying nucleic acid ligands. With a total of 7 patents to his name, Wecker's work has had a profound impact on various applications in the pharmaceutical industry.
Latest Patents
One of Wecker's latest patents is titled "Systematic evolution of ligands by exponential enrichment: Chemi-SELEX." This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities, as measured by their ability to facilitate the formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.
Career Highlights
Throughout his career, Matthew Wecker has worked with prominent companies in the pharmaceutical sector, including Nexstar Pharmaceuticals, Inc. and Gilead Sciences, Inc. His expertise in the field has enabled him to contribute to groundbreaking research and development projects.
Collaborations
Wecker has collaborated with esteemed colleagues such as Larry M Gold and Bruce Eaton. These partnerships have further enhanced his innovative work and expanded the reach of his inventions.
Conclusion
Matthew Wecker's contributions to biotechnology and his innovative patents demonstrate his commitment to advancing the field. His work continues to influence the development of new therapeutic approaches and methodologies.